Terence Flynn
Stock Analyst at Morgan Stanley
(4.67)
# 817
Out of 5,020 analysts
1082
Total ratings
59.1%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Terence Flynn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Rated: Buy | $115 | $96.85 | +18.74% | 94 | Sep 28, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Sell | $40 | $61.46 | -34.92% | 51 | Sep 25, 2026 | |
| AMGN Amgen | Reiterated: Hold | $362 | $407.27 | -11.12% | 57 | Sep 22, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Buy | $665 | $506.74 | +31.23% | 55 | Sep 22, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $179 | $143.81 | +24.47% | 57 | Sep 20, 2026 | |
| ALMS Alumis | Reiterated: Buy | $39 → $29 | $7.21 | +302.22% | 11 | Sep 2, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $165 | $147.50 | +11.86% | 63 | Aug 20, 2026 | |
| MRNA Moderna | Reiterated: Hold | $39 → $89 | $188.94 | -52.90% | 37 | Aug 19, 2026 | |
| BHVN Biohaven | Reiterated: Buy | $18 → $19 | $13.14 | +44.60% | 19 | Aug 12, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $48 | $19.32 | +148.45% | 8 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $11 → $10 | $7.43 | +34.59% | 25 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $126 | $28.98 | +334.78% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 | $12.12 | +23.76% | 19 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.99 | - | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $22 → $23 | $25.23 | -8.84% | 16 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,347 → $1,419 | $1,149.85 | +23.41% | 80 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $64 → $65 | $57.63 | +12.79% | 30 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $516 → $515 | $571.38 | -9.87% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 | $28.12 | -0.43% | 60 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $278 → $296 | $259.93 | +13.88% | 54 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $294 | $258.66 | +13.66% | 58 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $730 → $758 | $734.81 | +3.16% | 60 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $222 → $231 | $222.82 | +3.67% | 62 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $38 | $23.34 | +62.81% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $13.71 | -34.35% | 28 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $32 → $33 | $55.44 | -40.48% | 13 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.14 | n/a | 11 | Sep 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.52 | n/a | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $16 | $40.54 | n/a | 13 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $12 | $2.63 | n/a | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €92.31 | €134.45 | n/a | 1 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $42.45 | $8.13 | n/a | 1 | Dec 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $16 | $88.32 | n/a | 2 | Mar 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $163 → $155 | $231.18 | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $75.22 | n/a | 1 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $31 | $6.50 | n/a | 4 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 | $32.48 | n/a | 4 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $38 | $8.46 | n/a | 1 | Nov 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $36 | $2.93 | n/a | 1 | Jul 21, 2015 |
BioNTech SE
Sep 28, 2026
Rated: Buy
Price Target: $115
Current: $96.85
Upside: +18.74%
Bristol-Myers Squibb Company
Sep 25, 2026
Reiterated: Sell
Price Target: $40
Current: $61.46
Upside: -34.92%
Amgen
Sep 22, 2026
Reiterated: Hold
Price Target: $362
Current: $407.27
Upside: -11.12%
Vertex Pharmaceuticals
Sep 22, 2026
Reiterated: Buy
Price Target: $665
Current: $506.74
Upside: +31.23%
Merck & Co.
Sep 20, 2026
Reiterated: Buy
Price Target: $179
Current: $143.81
Upside: +24.47%
Alumis
Sep 2, 2026
Reiterated: Buy
Price Target: $39 → $29
Current: $7.21
Upside: +302.22%
Gilead Sciences
Aug 20, 2026
Reiterated: Buy
Price Target: $165
Current: $147.50
Upside: +11.86%
Moderna
Aug 19, 2026
Reiterated: Hold
Price Target: $39 → $89
Current: $188.94
Upside: -52.90%
Biohaven
Aug 12, 2026
Reiterated: Buy
Price Target: $18 → $19
Current: $13.14
Upside: +44.60%
Legend Biotech
Aug 12, 2026
Reiterated: Buy
Price Target: $48
Current: $19.32
Upside: +148.45%
Aug 10, 2026
Rated: Hold
Price Target: $11 → $10
Current: $7.43
Upside: +34.59%
Aug 10, 2026
Rated: Buy
Price Target: $126
Current: $28.98
Upside: +334.78%
Aug 10, 2026
Rated: Hold
Price Target: $15
Current: $12.12
Upside: +23.76%
Aug 10, 2026
Rated: Hold
Price Target: n/a
Current: $2.99
Upside: -
Aug 10, 2026
Rated: Hold
Price Target: $22 → $23
Current: $25.23
Upside: -8.84%
Aug 6, 2026
Reiterated: Buy
Price Target: $1,347 → $1,419
Current: $1,149.85
Upside: +23.41%
Aug 6, 2026
Rated: Buy
Price Target: $64 → $65
Current: $57.63
Upside: +12.79%
Aug 6, 2026
Rated: Hold
Price Target: $516 → $515
Current: $571.38
Upside: -9.87%
Aug 4, 2026
Reiterated: Hold
Price Target: $28
Current: $28.12
Upside: -0.43%
Aug 3, 2026
Rated: Buy
Price Target: $278 → $296
Current: $259.93
Upside: +13.88%
Aug 3, 2026
Reiterated: Buy
Price Target: $294
Current: $258.66
Upside: +13.66%
Jul 31, 2026
Reiterated: Hold
Price Target: $730 → $758
Current: $734.81
Upside: +3.16%
Jul 30, 2026
Reiterated: Hold
Price Target: $222 → $231
Current: $222.82
Upside: +3.67%
Jul 28, 2026
Rated: Buy
Price Target: $36 → $38
Current: $23.34
Upside: +62.81%
Apr 10, 2026
Reiterated: Hold
Price Target: $9
Current: $13.71
Upside: -34.35%
Feb 17, 2026
Reiterated: Sell
Price Target: $32 → $33
Current: $55.44
Upside: -40.48%
Sep 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.14
Upside: n/a
Dec 13, 2024
Reiterated: Hold
Price Target: n/a
Current: $2.52
Upside: n/a
Jun 1, 2021
Reiterated: Sell
Price Target: $16
Current: $40.54
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $21 → $12
Current: $2.63
Upside: n/a
Aug 3, 2020
Upgraded: Buy
Price Target: €92.31
Current: €134.45
Upside: n/a
Dec 2, 2019
Initiated Coverage: Hold
Price Target: $42.45
Current: $8.13
Upside: n/a
Mar 25, 2019
Downgraded: Hold
Price Target: $18 → $16
Current: $88.32
Upside: n/a
Aug 13, 2018
Reiterated: Buy
Price Target: $163 → $155
Current: $231.18
Upside: n/a
Jun 18, 2018
Initiated Coverage: Hold
Price Target: $22
Current: $75.22
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $32 → $31
Current: $6.50
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $46
Current: $32.48
Upside: n/a
Nov 18, 2015
Rated: Hold
Price Target: $38
Current: $8.46
Upside: n/a
Jul 21, 2015
Initiated Coverage: Hold
Price Target: $36
Current: $2.93
Upside: n/a